Cargando…

Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis

Ulcerative colitis is characterized by ulcers and inflammation of the inner lining of the gastrointestinal tract. Antitumor necrosis factor alpha (anti-TNF alpha) agents such as infliximab are drugs that have been used for the treatment of ulcerative colitis for decades. Infliximab is known to be as...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirza, Muhammad, Mirza, Maira, Murugesan, Vagishwari, Olano, Arrel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247658/
https://www.ncbi.nlm.nih.gov/pubmed/30533230
http://dx.doi.org/10.1155/2018/4324592
_version_ 1783372526041169920
author Mirza, Muhammad
Mirza, Maira
Murugesan, Vagishwari
Olano, Arrel
author_facet Mirza, Muhammad
Mirza, Maira
Murugesan, Vagishwari
Olano, Arrel
author_sort Mirza, Muhammad
collection PubMed
description Ulcerative colitis is characterized by ulcers and inflammation of the inner lining of the gastrointestinal tract. Antitumor necrosis factor alpha (anti-TNF alpha) agents such as infliximab are drugs that have been used for the treatment of ulcerative colitis for decades. Infliximab is known to be associated with various adverse effects including anti-TNF alpha induced lupus (ATIL). We present a rare case of a 51-year-old female with pericardial effusion secondary to infliximab therapy for treatment of her ulcerative colitis. Discontinuation of infliximab led to resolution of the pericardial effusion.
format Online
Article
Text
id pubmed-6247658
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-62476582018-12-09 Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis Mirza, Muhammad Mirza, Maira Murugesan, Vagishwari Olano, Arrel Case Rep Gastrointest Med Case Report Ulcerative colitis is characterized by ulcers and inflammation of the inner lining of the gastrointestinal tract. Antitumor necrosis factor alpha (anti-TNF alpha) agents such as infliximab are drugs that have been used for the treatment of ulcerative colitis for decades. Infliximab is known to be associated with various adverse effects including anti-TNF alpha induced lupus (ATIL). We present a rare case of a 51-year-old female with pericardial effusion secondary to infliximab therapy for treatment of her ulcerative colitis. Discontinuation of infliximab led to resolution of the pericardial effusion. Hindawi 2018-11-06 /pmc/articles/PMC6247658/ /pubmed/30533230 http://dx.doi.org/10.1155/2018/4324592 Text en Copyright © 2018 Muhammad Mirza et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Mirza, Muhammad
Mirza, Maira
Murugesan, Vagishwari
Olano, Arrel
Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
title Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
title_full Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
title_fullStr Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
title_full_unstemmed Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
title_short Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
title_sort pericardial effusion due to infliximab therapy for ulcerative colitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247658/
https://www.ncbi.nlm.nih.gov/pubmed/30533230
http://dx.doi.org/10.1155/2018/4324592
work_keys_str_mv AT mirzamuhammad pericardialeffusionduetoinfliximabtherapyforulcerativecolitis
AT mirzamaira pericardialeffusionduetoinfliximabtherapyforulcerativecolitis
AT murugesanvagishwari pericardialeffusionduetoinfliximabtherapyforulcerativecolitis
AT olanoarrel pericardialeffusionduetoinfliximabtherapyforulcerativecolitis